Ebola virus vaccine - GenPhar
Latest Information Update: 21 Mar 2007
At a glance
- Originator GenPhar
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Clinical Phase Unknown Ebola virus infections
Most Recent Events
- 21 Mar 2007 Clinical trials in Ebola virus infections in USA (Parenteral)
- 23 Oct 2002 Preclinical trials in Ebola virus infections in USA (Parenteral)